Clinical Trials
2 trialsNCT06003231 2026-06-01
A Study of Disitamab Vedotin in Previously Treated Solid Tumors That Express HER2
Seagen Inc.
Phase 2 Active not recruiting
NCT05898373 2023-06-12
Vedicitumomab Alone or in Combination for the Treatment of Locally Advanced or Metastatic SDC
Peking Union Medical College
Phase 1/2 Not yet recruiting